Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
about
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Glucagon-Like Peptide-1 (GLP-1 ...... ith Polycystic Ovary Syndrome.
@en
Glucagon-Like Peptide-1
@nl
type
label
Glucagon-Like Peptide-1 (GLP-1 ...... ith Polycystic Ovary Syndrome.
@en
Glucagon-Like Peptide-1
@nl
prefLabel
Glucagon-Like Peptide-1 (GLP-1 ...... ith Polycystic Ovary Syndrome.
@en
Glucagon-Like Peptide-1
@nl
P1476
Glucagon-Like Peptide-1 (GLP-1 ...... ith Polycystic Ovary Syndrome.
@en
P2093
Niki Katsiki
Themistoklis Tzotzas
P304
P356
10.2174/1570161114666161221115324
P577
2016-12-21T00:00:00Z